Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Novo Nordisk (NVO) stock in focus as oral Wegovy is accepted for FDA review for chronic weight management. Read more here.

The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a ...

The recipients include innovators who have created breakthroughs in knowledge and technology that are improving our world and ...

Review highlights how excessive fructose intake disrupts brain energy balance, appetite regulation, and cognitive function.

The Strategy posted positive absolute returns but slightly trailed its benchmark as detractors in consumer staples overcame ...

Novo Nordisk A/S slumped after a pill from rival Eli Lilly & Co. helped patients shed weight and control blood sugar about as ...

Shares of Novo Nordisk, the Danish pharmaceutical company behind the groundbreaking GLP-1 weight loss drugs Ozempic and Wegovy, have been absolutely plummeting. The company's stock price slid over ...

See reviews below to learn more or submit your own review. TXU Energy provides electricity and energy services. Operating mostly in Texas, it delivers residential and commercial electric plans ...

Unfortunately, what's good news for Eli Lilly is probably bad news for investors in Novo Nordisk and Viking Therapeutics, both of which lag Lilly in the race to develop their own easy-to-take GLP ...

Although Windows 10 generally does a good job of managing your device energy, you might still encounter issues like rapid battery drain or inefficient energy usage. In such cases, generating a ...

The move gives Novo Nordisk and Eli Lilly a bit more time of having the only patent-protected GLP-1 drugs on the market. Viking Therapeutics moves toward the head of the pack to become No. 3 ...